16-2088569-C-T

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_000548.5(TSC2):​c.5383C>T​(p.Arg1795Cys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00184 in 1,609,942 control chromosomes in the GnomAD database, including 2 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R1795H) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.0015 ( 0 hom., cov: 33)
Exomes 𝑓: 0.0019 ( 2 hom. )

Consequence

TSC2
NM_000548.5 missense

Scores

7
9
2

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts U:1B:28O:2

Conservation

PhyloP100: 0.424

Publications

37 publications found
Variant links:
Genes affected
TSC2 (HGNC:12363): (TSC complex subunit 2) This gene is a tumor suppressor gene that encodes the growth inhibitory protein tuberin. Tuberin interacts with hamartin to form the TSC protein complex which functions in the control of cell growth. This TSC protein complex negatively regulates mammalian target of rapamycin complex 1 (mTORC1) signaling which is a major regulator of anabolic cell growth. Mutations in this gene have been associated with tuberous sclerosis and lymphangioleiomyomatosis. [provided by RefSeq, May 2022]
PKD1 (HGNC:9008): (polycystin 1, transient receptor potential channel interacting) This gene encodes a member of the polycystin protein family. The encoded glycoprotein contains a large N-terminal extracellular region, multiple transmembrane domains and a cytoplasmic C-tail. It is an integral membrane protein that functions as a regulator of calcium permeable cation channels and intracellular calcium homoeostasis. It is also involved in cell-cell/matrix interactions and may modulate G-protein-coupled signal-transduction pathways. It plays a role in renal tubular development, and mutations in this gene cause autosomal dominant polycystic kidney disease type 1 (ADPKD1). ADPKD1 is characterized by the growth of fluid-filled cysts that replace normal renal tissue and result in end-stage renal failure. Splice variants encoding different isoforms have been noted for this gene. Also, six pseudogenes, closely linked in a known duplicated region on chromosome 16p, have been described. [provided by RefSeq, Oct 2008]
PKD1 Gene-Disease associations (from GenCC):
  • autosomal dominant polycystic kidney disease
    Inheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: Orphanet, ClinGen
  • polycystic kidney disease 1
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Laboratory for Molecular Medicine, Genomics England PanelApp, Labcorp Genetics (formerly Invitae)
  • autosomal recessive polycystic kidney disease
    Inheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
  • Caroli disease
    Inheritance: AD Classification: STRONG Submitted by: Genomics England PanelApp

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.038369924).
BP6
Variant 16-2088569-C-T is Benign according to our data. Variant chr16-2088569-C-T is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 41748.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population amr. GnomAd4 allele frequency = 0.00152 (232/152338) while in subpopulation AMR AF = 0.00457 (70/15308). AF 95% confidence interval is 0.00371. There are 0 homozygotes in GnomAd4. There are 117 alleles in the male GnomAd4 subpopulation. Median coverage is 33. This position passed quality control check.
BS2
High AC in GnomAd4 at 232 AD gene.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_000548.5. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
TSC2
NM_000548.5
MANE Select
c.5383C>Tp.Arg1795Cys
missense
Exon 42 of 42NP_000539.2P49815-1
TSC2
NM_001406663.1
c.5380C>Tp.Arg1794Cys
missense
Exon 42 of 42NP_001393592.1A0A2R8Y6C9
TSC2
NM_001114382.3
c.5314C>Tp.Arg1772Cys
missense
Exon 41 of 41NP_001107854.1P49815-4

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
TSC2
ENST00000219476.9
TSL:5 MANE Select
c.5383C>Tp.Arg1795Cys
missense
Exon 42 of 42ENSP00000219476.3P49815-1
TSC2
ENST00000350773.9
TSL:1
c.5314C>Tp.Arg1772Cys
missense
Exon 41 of 41ENSP00000344383.4P49815-4
TSC2
ENST00000401874.7
TSL:1
c.5182C>Tp.Arg1728Cys
missense
Exon 40 of 40ENSP00000384468.2P49815-5

Frequencies

GnomAD3 genomes
AF:
0.00152
AC:
232
AN:
152220
Hom.:
0
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.000338
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00458
Gnomad ASJ
AF:
0.00317
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000207
Gnomad FIN
AF:
0.0000941
Gnomad MID
AF:
0.00316
Gnomad NFE
AF:
0.00190
Gnomad OTH
AF:
0.00239
GnomAD2 exomes
AF:
0.00148
AC:
365
AN:
246520
AF XY:
0.00140
show subpopulations
Gnomad AFR exome
AF:
0.000375
Gnomad AMR exome
AF:
0.00194
Gnomad ASJ exome
AF:
0.00351
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.000740
Gnomad NFE exome
AF:
0.00197
Gnomad OTH exome
AF:
0.00198
GnomAD4 exome
AF:
0.00187
AC:
2723
AN:
1457604
Hom.:
2
Cov.:
33
AF XY:
0.00182
AC XY:
1319
AN XY:
725302
show subpopulations
African (AFR)
AF:
0.000657
AC:
22
AN:
33478
American (AMR)
AF:
0.00172
AC:
77
AN:
44708
Ashkenazi Jewish (ASJ)
AF:
0.00272
AC:
71
AN:
26130
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39700
South Asian (SAS)
AF:
0.000429
AC:
37
AN:
86254
European-Finnish (FIN)
AF:
0.000649
AC:
32
AN:
49334
Middle Eastern (MID)
AF:
0.00104
AC:
6
AN:
5764
European-Non Finnish (NFE)
AF:
0.00214
AC:
2378
AN:
1111886
Other (OTH)
AF:
0.00166
AC:
100
AN:
60350
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.472
Heterozygous variant carriers
0
159
318
478
637
796
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
88
176
264
352
440
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00152
AC:
232
AN:
152338
Hom.:
0
Cov.:
33
AF XY:
0.00157
AC XY:
117
AN XY:
74480
show subpopulations
African (AFR)
AF:
0.000337
AC:
14
AN:
41580
American (AMR)
AF:
0.00457
AC:
70
AN:
15308
Ashkenazi Jewish (ASJ)
AF:
0.00317
AC:
11
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5182
South Asian (SAS)
AF:
0.000207
AC:
1
AN:
4832
European-Finnish (FIN)
AF:
0.0000941
AC:
1
AN:
10622
Middle Eastern (MID)
AF:
0.00340
AC:
1
AN:
294
European-Non Finnish (NFE)
AF:
0.00190
AC:
129
AN:
68024
Other (OTH)
AF:
0.00237
AC:
5
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.498
Heterozygous variant carriers
0
12
24
36
48
60
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00123
Hom.:
0
Bravo
AF:
0.00143
TwinsUK
AF:
0.00351
AC:
13
ALSPAC
AF:
0.00208
AC:
8
ESP6500AA
AF:
0.000228
AC:
1
ESP6500EA
AF:
0.00186
AC:
16
ExAC
AF:
0.00120
AC:
145
EpiCase
AF:
0.00207
EpiControl
AF:
0.00213

ClinVar

ClinVar submissions
Significance:Benign/Likely benign
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
12
not provided (12)
-
-
5
not specified (5)
-
-
4
Tuberous sclerosis 2 (4)
-
-
3
Tuberous sclerosis syndrome (4)
-
-
2
Hereditary cancer-predisposing syndrome (2)
-
-
1
Lymphangiomyomatosis (1)
-
-
1
Lymphangiomyomatosis;C1846385:Isolated focal cortical dysplasia type II;C1860707:Tuberous sclerosis 2 (1)
-
1
-
Tuberous sclerosis and lymphangiomyomatosis (1)
-
-
-
Tuberous sclerosis syndrome;C0751674:Lymphangiomyomatosis (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
0.62
BayesDel_addAF
Uncertain
0.15
D
BayesDel_noAF
Pathogenic
0.44
CADD
Pathogenic
27
DANN
Uncertain
1.0
DEOGEN2
Uncertain
0.72
D
Eigen
Uncertain
0.26
Eigen_PC
Benign
0.21
FATHMM_MKL
Uncertain
0.77
D
LIST_S2
Pathogenic
0.99
D
M_CAP
Pathogenic
0.90
D
MetaRNN
Benign
0.038
T
MetaSVM
Pathogenic
0.83
D
MutationAssessor
Uncertain
2.5
M
PhyloP100
0.42
PrimateAI
Uncertain
0.72
T
PROVEAN
Uncertain
-3.3
D
REVEL
Pathogenic
0.81
Sift
Pathogenic
0.0
D
Sift4G
Uncertain
0.0020
D
Polyphen
1.0
D
Vest4
0.85
MVP
0.98
ClinPred
0.023
T
GERP RS
4.6
Varity_R
0.42
gMVP
0.62
Mutation Taster
=96/4
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs45517423; hg19: chr16-2138570; COSMIC: COSV51920139; COSMIC: COSV51920139; API
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.